| Title | Author(s) | Year | View Count |
 | An effective strategy for the synthesis of biocompatible gold nanoparticles using danshensu antioxidant: prevention of cytotoxicity via attenuation of free radical formation | Du, L; Miao, X; Jiang, Y; Jia, H; Tian, Q; Shen, J; Liu, Y | 2013 | 111 |
 | Effects of hydrogen bond and solvent polarity on the C=O strectching of bis(2-thienyl)ketone in solution | Wang, H; Wang, LB; Shen, SS; Zhang, WF; Li, M; Du, L; Zheng, XM; Phillips, DL | 2012 | 114 |
 | CL-385319 inhibits H5N1 avian influenza A virus infection by blocking viral entry | Liu, S; Li, R; Zhang, R; Chan, CCS; Xi, B; Zhu, Z; Yang, J; Poon, VKM; Zhou, J; Chen, M; Münch, J; Kirchhoff, F; Pleschka, S; Haarmann, T; Dietrich, U; Pan, C; Du, L; Jiang, S; Zheng, B | 2011 | 295 |
| A recombinant vaccine of H5N1 HA1 fused with foldon and human IgG Fc induced complete cross-clade protection against divergent H5N1 viruses | Du, L; Leung, VHC; Zhang, X; Zhou, J; Chen, M; He, W; Zhang, HY; Chan, CCS; Poon, VKM; Zhao, G; Sun, S; Cai, L; Zhou, Y; Zheng, BJ; Jiang, S | 2011 | 672 |
| A recombinant vaccine of H5N1 HA1 fused with foldon and human IgG Fc induced complete cross-clade protection against divergent H5N1 viruses | Du, L; Leung, VHC; Jiang, S; Zheng, B | 2011 | 155 |
| An M2e-based polypeptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses. | Zhao, G; Lin, Y; Guan, J; Du, L; Sui, H; Chan, CS; Kou, Z; Guo, Y; Jiang, S; Zhou, Y; Zheng, B | 2011 | 153 |
| An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus | Zhao, G; Sun, S; Du, L; Xiao, W; Ru, Z; Kou, Z; Guo, Y; Yu, H; Jiang, S; Lone, Y; Zheng, BJ; Zhou, Y | 2010 | 269 |
| An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses | Zhao, G; Lin, Y; Du, L; Guan, J; Sun, S; Sui, H; Kou, Z; Chan, CC; Guo, Y; Jiang, S; Zheng, BJ; Zhou, Y | 2010 | 515 |
| Development of a safe and convenient neutralization assay for rapid screening of influenza HA-specific neutralizing monoclonal antibodies | Du, L; Zhao, G; Zhang, X; Liu, Z; Yu, H; Zheng, BJ; Zhou, Y; Jiang, S | 2010 | 682 |
| Induction of protection against divergent H5N1 influenza viruses using a recombinant fusion protein linking influenza M2e to Onchocerca volvulus activation associated protein-1 (ASP-1) adjuvant | Zhao, G; Du, L; Xiao, W; Sun, S; Lin, Y; Chen, M; Kou, Z; He, Y; Lustigman, S; Jiang, S; Zheng, BJ; Zhou, Y | 2010 | 273 |
| A 219-mer CHO-expressing receptor-binding domain of SARS-CoV S protein induces potent immune responses and protective immunity | Du, L; Zhao, G; Chan, CC; Li, L; He, Y; Zhou, Y; Zheng, BJ; Jiang, S | 2010 | 292 |
| SARS-CoV S protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection | Zheng, B; Du, L; Zhao, G; Lin, Y; Sui, H; Chan, CS; He, Y; Jiang, S; Zhou, Y; Yuen, KY | 2010 | 191 |
| Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity | Du, L; Zhao, G; Chan, CCS; Sun, S; Chen, M; Liu, Z; Guo, H; He, Y; Zhou, Y; Zheng, BJ; Jiang, S | 2009 | 401 |
| Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells | Du, L; Zhao, G; Li, L; He, Y; Zhou, Y; Zheng, BJ; Jiang, S | 2009 | 191 |
| The spike protein of SARS-CoV - A target for vaccine and therapeutic development | Du, L; He, Y; Zhou, Y; Liu, S; Zheng, BJ; Jiang, S | 2009 | 57 |
| Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection | Du, L; Zhao, G; Lin, Y; Chan, C; He, Y; Jiang, S; Wu, C; Jin, DY; Yuen, KY; Zhou, Y; Zheng, BJ | 2008 | 138 |
| Development of subunit vaccines against severe acute respiratory symptom. | Du, L; Jian, S; Zheng, B | 2008 | 82 |
| Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection | Du, L; Zhao, G; Lin, Y; Sui, H; Chan, C; Ma, S; He, Y; Jiang, S; Wu, C; Yuen, KY; Jin, DY; Zhou, Y; Zheng, BJ | 2008 | 323 |
| SARS-CoV S protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection | Zheng, B; Du, L; Zhao, G; Lin, Y; Sui, H; Chan, CS; He, Y; Jiang, S; Wu, C; Jin, D; Zhou, Y; Yuen, KY | 2008 | 565 |
| Development of subunit vaccines against severe acute respiratory syndrome | Du, L; He, Y; Jiang, S; Zheng, BJ | 2008 | 47 |
|
